Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients (RADAR)
This study is ongoing, but not recruiting participants.
Sponsor:
Dallas VA Medical Center
Collaborators:
Merck
Tibotec Pharmaceutical Limited
Information provided by (Responsible Party):
Roger Bedimo, M.D., Dallas VA Medical Center
ClinicalTrials.gov Identifier:
NCT00677300
First received: May 8, 2008
Last updated: August 31, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2012 |
| Estimated Primary Completion Date: | October 2012 (Final data collection date for primary outcome measure) |